Long-term treatment results for nasopharyngeal carcinoma: The Sahlgrenska University Hospital experience
Open Access
- 1 January 2007
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 46 (6), 817-827
- https://doi.org/10.1080/02841860601016062
Abstract
Nasopharyngeal carcinoma (NPC) is a rare disease in Sweden. For evaluation of the treatment outcomes in our NPC patients, 52 new cases that were referred to our department between 1991 and 2002 were retrospectively analysed. Tumor stage, according to the 1997 AJCC staging system, was I in five, II in ten, III in 12 and IV in 25 patients. Majority of the patients (87%) had World Health Organization type II-III tumors. Neoadjuvant chemotherapy was delivered in 33 patients. Thirty-two patients received hyperfractionated accelerated radiation therapy with a median dose of 64.6Gy (1.7Gy/fr bid). Conventional external irradiation with a median dose of 66Gy (2Gy/fr) was delivered to 18 patients. An intracavitary brachy-boost of 4.5–12Gy was delivered to 40 patients. Two patients were excluded from the analysis due to treatment refusal. For the patients with tumor stages I-IVB, the 5-year disease-free and overall survival rates were 61% and 55%, respectively. The 5-year local, regional, and distant relapse-free survival rates were 70%, 92% and 77%, respectively. The most frequent late side effects were xerostomia (98%), otitis (70%) and hearing deterioration (64%). Our data suggest that optimization of the treatment outcomes in NPC patients requires implementation of new therapeutic strategies.Keywords
This publication has 20 references indexed in Scilit:
- Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patientsInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy aloneInternational Journal of Radiation Oncology*Biology*Physics, 2005
- The potential of proton beam radiation therapy in head and neck cancerActa Oncologica, 2005
- The potential of proton beam therapy in paediatric cancerActa Oncologica, 2005
- Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2004
- The Additional Value of Chemotherapy to Radiotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Meta-Analysis of the Published LiteratureJournal of Clinical Oncology, 2004
- Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalationInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?International Journal of Radiation Oncology*Biology*Physics, 2002
- Lent soma scales for all anatomic sitesInternational Journal of Radiation Oncology*Biology*Physics, 1995
- The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: An analysis of 1301 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1994